Myeung Hoon Jo
Overview
Explore the profile of Myeung Hoon Jo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jo M, Ikram M, Jo M, Yoo L, Chung K, Nah S, et al.
Mol Neurobiol
. 2024 Apr;
61(7):4926.
PMID: 38625622
No abstract available.
2.
Park J, Choe K, Khan A, Jo M, Park H, Kang M, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982361
The blood-brain barrier (BBB) is a functional interface that provides selective permeability, protection from toxic substances, transport of nutrients, and clearance of brain metabolites. Additionally, BBB disruption has been shown...
3.
Park J, Saeed K, Jo M, Kim M, Lee H, Park C, et al.
Antioxidants (Basel)
. 2022 Feb;
11(2).
PMID: 35204143
Age-related decline in mitochondrial function and oxidative stress plays a critical role in neurodegeneration. Lactate dehydrogenase-B (LDHB) is a glycolytic enzyme that catalyzes the conversion of lactate, an important brain...
4.
Saeed K, Jo M, Park J, Alam S, Khan I, Ahmad R, et al.
Antioxidants (Basel)
. 2021 Nov;
10(11).
PMID: 34829553
Disruptions in brain energy metabolism, oxidative damage, and neuroinflammation are commonly seen in traumatic brain injury (TBI). Microglial activation is the hallmark of neuroinflammation. After brain injury, microglia also act...
5.
Ikram M, Jo M, Choe K, Khan A, Ahmad S, Saeed K, et al.
Cells
. 2021 Oct;
10(10).
PMID: 34685699
Here, we have unveiled the effects of cycloastragenol against Aβ (Amyloid-beta)-induced oxidative stress, neurogenic dysfunction, activated mitogen-activated protein (MAP) kinases, and mitochondrial apoptosis in an Aβ-induced mouse model of Alzheimer's...
6.
Ahmad S, Jo M, Ikram M, Khan A, Kim M
Int J Mol Sci
. 2021 Sep;
22(17).
PMID: 34502488
The current study was undertaken to unveil the protective effects of Luteolin, a natural flavonoid, against amyloid-beta (Aβ-)-induced neuroinflammation, amyloidogenesis, and synaptic dysfunction in mice. For the development of an...
7.
Ikram M, Jo M, Park T, Kim M, Khan I, Jo M, et al.
Oxid Med Cell Longev
. 2021 May;
2021:6635552.
PMID: 33953832
The study was aimed at analyzing the protective effects of gintonin in an amyloid beta- (A-) induced Alzheimer's disease (AD) mouse model. For the development of the A-induced AD mouse...
8.
Ali T, Rehman S, Khan A, Badshah H, Bin Abid N, Kim M, et al.
Mol Neurodegener
. 2021 Apr;
16(1):23.
PMID: 33849621
Background: Recently, we and other researchers reported that brain metabolic disorders are implicated in Alzheimer's disease (AD), a progressive, devastating and incurable neurodegenerative disease. Hence, novel therapeutic approaches are urgently...
9.
Ahmad S, Khan A, Ali W, Jo M, Park J, Ikram M, et al.
Front Pharmacol
. 2021 Mar;
12:612078.
PMID: 33716741
Herein, we have evaluated the protective potentials of Fisetin against d-galactose-induced oxidative stress, neuroinflammation, and memory impairment in mice. d-galactose (D-gal) causes neurological impairment by inducing reactive oxygen species (ROS),...
10.
Saeed K, Shah S, Ullah R, Alam S, Park J, Saleem S, et al.
Oxid Med Cell Longev
. 2020 Dec;
2020:9523758.
PMID: 33274012
Alzheimer's disease (AD) is a progressive neurodegenerative disorder typified by several neuropathological features including amyloid-beta (A) plaque and neurofibrillary tangles (NFTs). Cholesterol retention and oxidative stress (OS) are the major...